222
Views
9
CrossRef citations to date
0
Altmetric
Research Articles

Compensation Effects on Clinical Trial Data Collection in Opioid-Dependent Young Adults

, M.D., , M.D., & , M.D.
Pages 81-86 | Published online: 22 Sep 2011

REFERENCES

  • Dutra L, Stathopoulou G, Basden SL, Leyro TM, Powers MB, Otto MW. A meta-analytic review of psychosocial interventions for substance use disorders. Am J Psychiatry 2008; 165(2):179–187.
  • Mattson ME, Del Boca FK, Carroll KM, Cooney NL, Di Clemente CC, Donovan D, Kadden RM, McRee B, Rice C, Rycharik RG, Zweben A. Compliance with treatment and follow-up protocols in project MATCH: Predictors and relationship to outcome. Alcohol Clin Exp Res 1998; 22(6):1328–1339.
  • Lavori PW, Bloch DA, Bridge PT, Leiderman DB, Locastro JS, Somoza E. Plans, designs, and analyses for clinical trials of anti-cocaine medications: Where we are today, NIDA/VA/SU Working Group on Design and Analysis. J Clin Psychopharmacol 1999; 19(3):246–256.
  • Agosti V, Nunes E, Ocepeck-Welikson K. Patient factors related to early attrition from an outpatient cocaine research clinic. Am J Drug Alcohol Abuse 1996; 22(1Money Management in Substance Abusers (Guest Editor: Marc Rosen)):29–39.
  • Cottler LB, Compton WM, Ben-Abdallah A, Horne M, Claverie D. Achieving a 96.6 percent follow-up rate in a longitudinal study of drug abusers. Drug Alcohol Depend 1996; 41(3):209–217.
  • Scott CK. A replicable model for achieving over 90% follow-up rates in longitudinal studies of substance abusers. Drug Alcohol Depend 2004; 74(1Money Management in Substance Abusers (Guest Editor: Marc Rosen)):21–36.
  • Fielding S, Fayers PM, Ramsay CR. Investigating the missing data mechanism in quality of life outcomes: A comparison of approaches. Health Qual Life Outcomes 2009; 7:57.
  • Hedden SL, Woolson RF, Carter RE, Palesch Y, Upadhyaya HP, Malcolm RJ. The impact of loss to follow-up on hypothesis tests of the treatment effect for several statistical methods in substance abuse clinical trials. J Subst Abuse Treat 2009; 37(1Money Management in Substance Abusers (Guest Editor: Marc Rosen)):54–63.
  • Delucchi KL. Methods for the analysis of binary outcome results in the presence of missing data. J Consult Clin Psychol 1994; 62(3):569–575.
  • Arndt S. Stereotyping and the treatment of missing data for drug and alcohol clinical trials. Subst Abuse Treat Prev Policy 2009; 4:2.
  • Carroll KM, Rounsaville BJ, Nich C, Gordon LT, Wirtz PW, Gawin F. One-year follow-up of psychotherapy and pharmacotherapy for cocaine dependence. Delayed emergence of psychotherapy effects. Arch Gen Psychiatry 1994; 51(12):989–997.
  • Nich C, Carroll KM. Intention-to-treat meets missing data: Implications of alternate strategies for analyzing clinical trials data. Drug Alcohol Depend 2002; 68(2):121–130.
  • Petry NM, Martin B, Cooney JL, Kranzler HR. Give them prizes, and they will come: Contingency management for treatment of alcohol dependence. J Consult Clin Psychol 2000; 68(2):250–257.
  • Higgins ST, Alessi SM, Dantona RL. Voucher-based incentives: A substance abuse treatment innovation. Addict Behav 2002; 27(6):887–910.
  • Dallery J, Silverman K, Chutuape MA, Bigelow GE, Stitzer ML. Voucher-based reinforcement of opiate plus cocaine abstinence in treatment-resistant methadone patients: Effects of reinforcer magnitude. Exp Clin Psychopharmacol 2001; 9(3):317–325.
  • Croft JR, Festinger DS, Dugosh KL, Marlowe DB, Rosenwasser BJ. Does size matter? Salience of follow-up payments in drug abuse research. IRB 2007; 29(4):15–19.
  • Festinger DS, Marlowe DB, Dugosh KL, Croft JR, Arabia PL. Higher magnitude cash payments improve research follow-up rates without increasing drug use or perceived coercion. Drug Alcohol Depend 2008; 96(1–2):128–135.
  • Festinger DS, Marlowe DB, Croft JR, Dugosh KL, Mastro NK, Lee PA, Dematteo DS, Patapis NS. Do research payments precipitate drug use or coerce participation? Drug Alcohol Depend 2005; 78(3):275–281.
  • Winters KC, Stinchfield RD, Opland E, Weller C, Latimer WW. The effectiveness of the Minnesota Model approach in the treatment of adolescent drug abusers. Addiction 2000; 95(4):601–612.
  • Meyers K, Webb A, Frantz J, Randall M. What does it take to retain substance-abusing adolescents in research protocols? Delineation of effort required, strategies undertaken, costs incurred, and 6-month post-treatment differences by retention difficulty. Drug Alcohol Depend 2003; 69(1Money Management in Substance Abusers (Guest Editor: Marc Rosen)):73–85.
  • Lott DC, Jencius S. Effectiveness of very low-cost contingency management in a community adolescent treatment program. Drug Alcohol Depend 2009; 102(1–3):162–165.
  • Kaminer Y. Contingency management reinforcement procedures for adolescent substance abuse. J Am Acad Child Adolesc Psychiatry 2000; 39(10):1324–1326.
  • Woody GE, Poole SA, Subramaniam G, Dugosh K, Bogenschutz M, Abbott P, Patkar A, Publicker M, McCain K, Potter JS, Forman R, Vetter V, McNicholas L, Blaine J, Lynch KG, Fudala P. Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: A randomized trial. JAMA 2008; 300(17):2003–2011.
  • Zuur AF, Leno EN, Walker NJ, Saveliev AA, Smith GM. Mixed Effects Models and Extensions in Ecology in R. New York: Springer, 2009.
  • Anderson EE, DuBois JM. The need for evidence-based research ethics: A review of the substance abuse literature. Drug Alcohol Depend 2007; 86(2–3):95–105.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.